Table 3.
Characteristics of studies included in this review
| Determinants included in the studya | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Authors | Countries (yeara) | Study design | Sample size, study population | Outcome | P | R | O | G | R | E | S | S | + |
| Ben Romdhane et al. (35) | Tunisia (2014) | Quantitative (cross-sectional) | 7,700 adults aged 35–70 years old | Prevalence, Awareness, Being untreated | ✓ | ✓ | ✓ | ✓ | ✓ | Age | |||
| Sosa-Rubi et al. (39) | Mexico (2009) | Quantitative (cross-sectional) | 2,960 diabetes patients aged 20–80 years old | Number of insulin injections per week | Health insurance | ||||||||
| Stephens et al. (40) | 15 LMICs (2013) | Quantitative (cross-sectional) | 202,468 prescription | Type of medication prescribed | ✓ | ||||||||
| Baumann et al. (34) | Uganda (2010) | Quantitative (cross-sectional) | 340 diabetes patients aged 30 years or over | Treated, self-management | ✓ | ||||||||
| Cunningham-Myrie et al. (36) | Jamaica (2013) | Quantitative (cross-sectional) | 2,848 adults aged 15 to 74 years old | Prevalence, Awareness, Being treated with any DM medication | ✓ | ✓ | ✓ | ✓ | Health insurance | ||||
| Le et al. (38) | Yunan, China (2011) | Quantitative (cross-sectional) | 10,007 adults aged 18 years or over in rural Yunan | Prevalence, Awareness, Being treated with any DM medication | ✓ | ✓ | ✓ | ✓ | Age | ||||
| Gakidou et al. (37) | Colombia (2007) | Quantitative (cross-sectional) | 7,284 adults aged 35–64 years old | Prevalence, Awareness, Being untreated, Being treated and controlled | ✓ | ||||||||
| Iran (2004) | Quantitative (cross-sectional) | 49,695 adults aged 35–64 years old | Prevalence, Awareness, Being untreated | ✓ | |||||||||
| Mexico (1994) | Quantitative (cross-sectional) | 30,602 adults aged 35 years or over | Prevalence, Awareness, Being untreated | ✓ | |||||||||
| Thailand (2008) | Quantitative (cross-sectional) | 33,058 adults aged 35 years or over | Prevalence, Awareness, Being untreated | ✓ | |||||||||
| Bhojani et al. (28) | India (2013) | Qualitative | 16 T2D patients aged 21–65 years old resided in urban slum of Bengaluru | Access to DM medication | ✓ | ✓ | ✓ | ||||||
| Chary et al. (29) | Guatemala (2012) | Mixed-method | 23 indigenous T2D patients resided in indigenous areas of Guatemala aged 18 years or over | Access to DM medication | ✓ | ✓ | |||||||
| Higuchi (30) | The Philippines (2010) | Mixed-method | 359 T2D patients, health policy workers, service providers | Access to DM medication, services for DM | ✓ | ✓ | Age | ||||||
| Balabanova et al. (26) | Georgia (2008) | Qualitative | 14 health policy workers, service providers; and 10 T1D adult patients | Access to insulin | ✓ | ✓ | Age | ||||||
| Kolling et al. (31) | Tanzania (2010) | Qualitative | 29 T2D patients living in impoverished areas of Dar es Salaam aged 32–70 years old 11 secondary informants (family members, providers, health service manager) | Access to DM medication | ✓ | ✓ | ✓ | Physical condition | |||||
| Rutebemberwa et al. (33) | Uganda (2013) | Qualitative | 32 T2D adults patients (in 4 FGD) in Eastern Uganda and 13 secondary informant | The tendency to use herbal for DM medication | ✓ | ✓ | ✓ | ||||||
| Belue et al. (27) | Mbour, Senegal (2012) | Qualitative | 54 adult diabetic patients attending outpatient clinic | Self-management, being treated | ✓ | ✓ | Health insurance | ||||||
a
PROGRESS+: Place of Residence, Race/ethnic, Occupation, Gender, Religion, Education, Socio-economic Status, Social Capital, Others. Check point (✓) indicates determinants included in each study. DM, diabetes mellitus; T1D, type 1 diabetes; T2D, type 2 diabetes; FGD, focus group discussion, LMICs, low- and middle-income countries.
a
Year refers to time of data collection.